Xin Yang, MD
Interventional Cardiology · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · Alameda Health System
Looking this up.
Hospitals listed: Alameda Hospital · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Highland Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Yang’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A111777 · Current
Licensed to practise in California · since 2010 · expires 2027-12-31 · University of Cambridge School of Clinical Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alameda HospitalAlameda, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Alameda Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.12) · 119 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.45 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 532 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,887 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,916 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.77 to 5.96) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.58 to 4.02) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,359 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2.4 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.6 · 242 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 244 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 40 cases | None | Jul 2023 – Jun 2025 |
What patients said (319 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$173,079
Medicare paid this office $173,079 for 1,076 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 95 | $52,249 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 522 | $32,703 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $29,868 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $12,612 | $160 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,454 | $390 |
See all 26 services
| Critical care, first 30-74 minutes | 95 | $52,249 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 522 | $32,703 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $29,868 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $12,612 | $160 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,454 | $390 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,724 | $69 |
| Critical care, each additional 30 minutes | 21 | $3,268 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,819 | $113 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,815 | $188 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 342 | $2,612 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,239 | $97 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 14 | $1,907 | $136 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 26 | $1,532 | $59 |
| Long return visit (40+ min) | 13 | $1,245 | $96 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 59 | $1,205 | $20 |
| Ultrasound of heart, follow-up | 40 | $903 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 69 | $898 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $327 | $16 |
| Heart muscle strain imaging | 29 | $273 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $235 | $11 |
| 3d radiographic procedure | 27 | $221 | $8 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $195 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 13 | $167 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 25 | $160 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 16 | $95 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $92 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,076 Original Medicare patients in 2024. Average age 72 · Under 65 17% · 85 and older 15% · Women 51% · Also on Medicaid 70% · Health risk score 2.39. Sicker patients than 9 in 10 peers; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Diabetes 44% · Chronic kidney disease 43% · Heart failure 41% · Coronary heart disease 37% · Atrial fibrillation 29% · Depression 29% · COPD 26% · Stroke 25% · Dementia 18% · Cancer 16%.
The office billed $902,899, Medicare allowed $219,906 and paid $173,079; for 2,229 services of 59 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,076 | 2,229 | 72 | 2.39 | $902,899 | $173,079 |
| 2023 | 1,267 | 2,410 | 71 | 2.19 | $842,104 | $146,633 |
| 2022 | 1,138 | 2,181 | 71 | 2.21 | $886,408 | $139,011 |
| 2021 | 1,557 | 2,975 | 71 | 2.21 | $1,052,751 | $160,355 |
| 2020 | 1,501 | 3,020 | 70 | 2.34 | $1,088,906 | $161,581 |
| 2019 | 1,536 | 3,071 | 73 | 2.09 | $1,117,895 | $257,096 |
| 2018 | 1,121 | 3,001 | 75 | 1.87 | $1,248,667 | $310,577 |
| 2017 | 1,225 | 3,122 | 75 | 1.96 | $1,295,515 | $298,468 |
| 2016 | 1,310 | 3,466 | 75 | 2.02 | $1,370,276 | $352,556 |
| 2015 | 1,277 | 3,185 | 75 | 1.94 | $1,095,001 | $322,812 |
| 2014 | 1,143 | 3,195 | 75 | 1.72 | $860,179 | $328,232 |
| 2013 | 959 | 2,736 | 75 | 1.82 | $794,146 | $278,711 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Critical care, first 30-74 minutes | 79 | $38,849 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $29,544 | $106 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 483 | $26,931 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $12,150 | $146 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,509 | $542 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 629 | $4,864 | $6 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $2,569 | $171 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,188 | $95 |
| Critical care, each additional 30 minutes | 20 | $2,144 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,709 | $71 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $1,550 | $141 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 20 | $1,049 | $52 |
| Ultrasound of heart, follow-up | 41 | $921 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 38 | $723 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 48 | $570 | $12 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $401 | $29 |
| Heart muscle strain imaging | 34 | $360 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $319 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $248 | $10 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $206 | $13 |
| 3d radiographic procedure | 17 | $147 | $9 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 24 | $146 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 34 | $116 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 36 | $100 | $3 |
2022: 18 services
| Critical care, first 30-74 minutes | 81 | $41,561 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $19,804 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 333 | $19,337 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $13,923 | $176 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 17 | $10,619 | $559 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 682 | $5,878 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,151 | $180 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $2,772 | $163 |
| Long return visit (40+ min) | 24 | $1,745 | $73 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,453 | $91 |
| Ultrasound of heart, follow-up | 32 | $816 | $23 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $651 | $34 |
| Programming of dual lead pacemaker system | 12 | $344 | $29 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $262 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $226 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $142 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 20 | $108 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $104 | $3 |
2021: 25 services
| Critical care, first 30-74 minutes | 89 | $41,383 | $192 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 321 | $20,462 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $12,509 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $12,163 | $179 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,130 | $10,622 | $7 |
| Long return visit (40+ min) | 50 | $8,244 | $127 |
| Telephone medical discussion with physician, 21-30 minutes | 76 | $8,129 | $66 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $8,029 | $401 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $7,224 | $556 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $6,208 | $200 |
| Return visit (30+ min) | 41 | $4,471 | $89 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $2,823 | $113 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,173 | $98 |
| Short return visit (20+ min) | 12 | $851 | $61 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $803 | $54 |
| Short return visit | 14 | $681 | $31 |
| Ultrasound of heart, follow-up | 19 | $503 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $433 | $11 |
| Programming of dual lead pacemaker system | 12 | $334 | $26 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $197 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $185 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $127 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $91 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 16 | $75 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $74 | $3 |
2020: 21 services
| Critical care, first 30-74 minutes | 74 | $48,657 | $199 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 277 | $17,827 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $13,110 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,103 | $11,119 | $7 |
| Telephone medical discussion with physician, 21-30 minutes | 102 | $10,647 | $70 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 15 | $8,728 | $582 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,364 | $180 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $6,205 | $388 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 38 | $4,846 | $128 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,650 | $211 |
| Return visit (30+ min) | 49 | $3,526 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,690 | $122 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $1,662 | $45 |
| Programming of dual lead pacemaker system | 27 | $1,102 | $30 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $846 | $60 |
| Short return visit (20+ min) | 16 | $644 | $40 |
| Ultrasound of heart, follow-up | 19 | $472 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $287 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $217 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $87 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $62 | $3 |
2019: 31 services
| Return visit (30+ min) | 400 | $42,688 | $82 |
| Critical care, first 30-74 minutes | 97 | $32,370 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $26,720 | $92 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 27 | $16,444 | $567 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 243 | $16,210 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $14,016 | $177 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 128 | $13,995 | $106 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 62 | $13,270 | $198 |
| Long return visit (40+ min) | 95 | $12,961 | $114 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,845 | $402 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $6,994 | $189 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 515 | $5,294 | $7 |
| Return visit (30+ min) | 54 | $4,268 | $68 |
| New patient visit (60+ min) | 22 | $3,441 | $156 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,658 | $140 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 12 | $2,294 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,052 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,806 | $62 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,372 | $98 |
| Insertion of blood flow assist device in aorta through skin | 11 | $1,326 | $121 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $859 | $61 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $705 | $54 |
| Ultrasound of heart, follow-up | 24 | $600 | $23 |
| Programming of dual lead pacemaker system | 11 | $380 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $339 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $281 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $260 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $248 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $244 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $105 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $90 | $3 |
2018: 26 services
| Return visit (30+ min) | 421 | $66,258 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 193 | $42,292 | $86 |
| Long return visit (40+ min) | 191 | $29,616 | $109 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 175 | $24,878 | $141 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $17,161 | $419 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $16,436 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $16,372 | $186 |
| Critical care, first 30-74 minutes | 62 | $12,661 | $181 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 68 | $12,494 | $178 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 170 | $10,571 | $61 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 22 | $9,553 | $434 |
| New patient visit (60+ min) | 36 | $5,925 | $165 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 33 | $5,866 | $89 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 34 | $4,568 | $127 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 17 | $3,701 | $218 |
| Injection, regadenoson, 0.1 mg | 20 | $3,546 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,471 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 39 | $2,109 | $54 |
| External shock to heart to regulate heart beat | 16 | $1,579 | $93 |
| Ultrasound of heart, follow-up | 36 | $751 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 38 | $560 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $241 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 36 | $213 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $162 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $128 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 43 | $112 | $3 |
2017: 30 services
| Return visit (30+ min) | 447 | $68,569 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 208 | $39,748 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 143 | $24,688 | $161 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 238 | $24,440 | $101 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $18,463 | $420 |
| Long return visit (40+ min) | 124 | $17,913 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $17,681 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 239 | $12,674 | $52 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 64 | $11,050 | $170 |
| Critical care, first 30-74 minutes | 57 | $10,579 | $176 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 19 | $7,644 | $402 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 24 | $4,266 | $89 |
| New patient visit (60+ min) | 24 | $3,882 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,830 | $59 |
| Injection, regadenoson, 0.1 mg | 17 | $2,951 | None |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,572 | $129 |
| New patient visit (45+ min) | 21 | $2,141 | $102 |
| Long return visit (40+ min) | 21 | $1,903 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 30 | $1,748 | $56 |
| Ultrasound of both sides of head and neck blood flow | 11 | $1,551 | $141 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,437 | $90 |
| External shock to heart to regulate heart beat | 12 | $1,098 | $91 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $737 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $732 | $13 |
| Ultrasound of heart, follow-up | 33 | $699 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $347 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $243 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $233 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $198 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 48 | $129 | $3 |
2016: 34 services
| Return visit (30+ min) | 457 | $79,756 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 278 | $56,912 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 183 | $34,420 | $173 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 222 | $26,013 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 321 | $18,073 | $55 |
| Critical care, first 30-74 minutes | 69 | $15,708 | $189 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 71 | $14,521 | $205 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $13,637 | $470 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 56 | $11,982 | $210 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 22 | $11,260 | $512 |
| Long return visit (40+ min) | 70 | $7,826 | $103 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,762 | $431 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 28 | $5,343 | $95 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 30 | $4,775 | $154 |
| New patient visit (45+ min) | 30 | $3,866 | $129 |
| Injection, regadenoson, 0.1 mg | 20 | $3,383 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,038 | $61 |
| External shock to heart to regulate heart beat | 20 | $2,105 | $105 |
| Long return visit (40+ min) | 21 | $2,006 | $96 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $1,926 | $62 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,893 | $105 |
| New patient visit (60+ min) | 11 | $1,867 | $170 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,776 | $93 |
| Emergency department visit with high level of medical decision making | 12 | $1,730 | $144 |
| Ultrasound of both sides of head and neck blood flow | 11 | $1,381 | $126 |
| Ultrasound of heart, follow-up | 36 | $806 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 49 | $776 | $15 |
| Electrocardiogram (ecg) 2-day continuous | 15 | $355 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $348 | $19 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $325 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $273 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 36 | $229 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $227 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 51 | $148 | $3 |
2015: 30 services
| Return visit (30+ min) | 435 | $75,677 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 217 | $39,026 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 289 | $29,933 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 130 | $24,205 | $173 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $19,869 | $211 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 28 | $16,323 | $453 |
| Critical care, first 30-74 minutes | 55 | $15,067 | $188 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $13,924 | $55 |
| Long return visit (40+ min) | 100 | $12,834 | $111 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 37 | $7,587 | $195 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,664 | $444 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 25 | $6,526 | $131 |
| New patient visit (60+ min) | 29 | $4,608 | $159 |
| New patient visit (45+ min) | 34 | $3,914 | $115 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $3,361 | $259 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 20 | $2,775 | $132 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,634 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,432 | $62 |
| Injection, regadenoson, 0.1 mg | 14 | $2,328 | None |
| Emergency department visit with high level of medical decision making | 16 | $2,151 | $134 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 28 | $1,735 | $62 |
| Long return visit (40+ min) | 15 | $1,341 | $89 |
| Ultrasound of heart, follow-up | 47 | $1,053 | $22 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $969 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 58 | $899 | $15 |
| Electrocardiogram (ecg) 2-day continuous | 27 | $708 | $25 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $636 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 25 | $418 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 47 | $299 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 71 | $214 | $3 |
2014: 30 services
| Return visit (30+ min) | 282 | $46,352 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 270 | $36,841 | $134 |
| Long return visit (40+ min) | 189 | $34,959 | $124 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 98 | $20,044 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 158 | $19,133 | $62 |
| New patient visit (45+ min) | 131 | $18,159 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 105 | $17,272 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $15,817 | $174 |
| Critical care, first 30-74 minutes | 63 | $13,906 | $188 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $13,101 | $437 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 231 | $12,985 | $55 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 53 | $11,849 | $114 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 46 | $9,722 | $198 |
| New patient visit (60+ min) | 28 | $5,065 | $181 |
| Injection, regadenoson, 0.1 mg | 29 | $4,566 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 51 | $3,006 | $59 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,783 | $146 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,326 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,235 | $118 |
| Emergency department visit with high level of medical decision making | 15 | $2,159 | $144 |
| Ultrasound of both sides of head and neck blood flow | 15 | $1,972 | $131 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,725 | $91 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $1,338 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 66 | $1,008 | $15 |
| Ultrasound of heart, follow-up | 33 | $802 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 30 | $716 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 30 | $638 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $305 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 34 | $236 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 53 | $164 | $3 |
2013: 31 services
| Return visit (30+ min) | 216 | $50,137 | $88 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 265 | $41,792 | $151 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 120 | $19,390 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $16,609 | $87 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 63 | $15,206 | $119 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $12,086 | $448 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 205 | $11,039 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $11,005 | $60 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 17 | $9,870 | $519 |
| Critical care, first 30-74 minutes | 32 | $9,587 | $184 |
| Injection, regadenoson, 0.1 mg | 46 | $7,804 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 36 | $7,321 | $198 |
| Long return visit (40+ min) | 50 | $7,300 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,185 | $167 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 29 | $6,013 | $207 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,464 | $114 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $4,183 | $63 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 30 | $4,065 | $131 |
| Hospital discharge day management, more than 30 minutes | 40 | $3,474 | $87 |
| New patient visit (45+ min) | 25 | $3,151 | $126 |
| New patient visit (60+ min) | 14 | $2,276 | $163 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,024 | $88 |
| External shock to heart to regulate heart beat | 11 | $1,290 | $99 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $1,275 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 53 | $922 | $15 |
| Ultrasound of heart, follow-up | 21 | $473 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 18 | $454 | $25 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 18 | $362 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $344 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 43 | $141 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $133 | $6 |
Medicaid work
$154,631 in 2024
Medicaid paid $154,631 for 3,848 billed services this clinician did in 2024, up to 352 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 538 | $74,269 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 775 | $34,505 |
| Return visit (30+ min) | 476 | $20,360 |
| Long return visit (40+ min) | 168 | $7,687 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,682 | $7,438 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 64 | $5,624 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 74 | $4,385 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 39 | $200 |
| Myocardial strain imaging using speckle tracking-derived assessment of myocardial mechanics (List separately in addition to codes for echocardiography imaging) | 15 | $162 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; scanning analysis with report | 17 | $0 |
| 2024 | 3,848 | 10 | 352 | $154,631 |
| 2023 | 5,114 | 8 | 280 | $147,978 |
| 2022 | 3,910 | 6 | 277 | $100,152 |
| 2021 | 4,757 | 4 | 397 | $60,373 |
| 2020 | 4,484 | 5 | 662 | $53,563 |
| 2019 | 2,069 | 5 | 350 | $25,665 |
| 2018 | 370 | 4 | 28 | $10,613 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 561 | $74,617 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 857 | $38,300 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,972 | $20,954 |
| Return visit (30+ min) | 341 | $6,740 |
| Long return visit (40+ min) | 291 | $4,391 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 36 | $2,550 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 12 | $243 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 44 | $182 |
2022
| Clinic visit/encounter, all-inclusive | 281 | $37,418 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 520 | $27,173 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,806 | $21,204 |
| Long return visit (40+ min) | 164 | $10,995 |
| Return visit (30+ min) | 122 | $3,363 |
| Short return visit | 17 | $0 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 4,128 | $29,971 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 550 | $28,555 |
| Return visit (30+ min) | 53 | $1,256 |
| Long return visit (40+ min) | 26 | $593 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3,851 | $27,061 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 479 | $23,769 |
| Return visit (30+ min) | 111 | $2,455 |
| Short return visit (20+ min) | 31 | $181 |
| Short return visit | 12 | $97 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,628 | $11,196 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 266 | $10,608 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 49 | $2,065 |
| Return visit (30+ min) | 98 | $1,622 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 28 | $174 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 130 | $5,377 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 192 | $4,205 |
| Long return visit (40+ min) | 17 | $517 |
| Return visit (30+ min) | 31 | $514 |
Drugs they prescribed that Part D paid
$131,063
Pharmacies billed $131,063 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,019) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
906 generic and 113 brand-name prescriptions · $131,063 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 33 | $41,796 | $1,267 |
| Xarelto | 17 | $27,242 | $1,602 |
| Jardiance | 31 | $25,843 | $834 |
| Metoprolol | 108 | $1,791 | $17 |
| Atorvastatin | 162 | $1,586 | $10 |
See all 22 drugs
| Eliquis | 33 | $41,796 | $1,267 |
| Xarelto | 17 | $27,242 | $1,602 |
| Jardiance | 31 | $25,843 | $834 |
| Metoprolol | 108 | $1,791 | $17 |
| Atorvastatin | 162 | $1,586 | $10 |
| Clopidogrel | 74 | $1,133 | $15 |
| Ezetimibe | 12 | $766 | $64 |
| Losartan | 60 | $680 | $11 |
| Lisinopril | 58 | $460 | $8 |
| Carvedilol | 52 | $410 | $8 |
| Nitroglycerin | 24 | $399 | $17 |
| Digoxin | 11 | $374 | $34 |
| Rosuvastatin | 12 | $349 | $29 |
| Metoprolol | 33 | $344 | $10 |
| Enalapril Maleate | 24 | $265 | $11 |
| Amlodipine Besylate | 47 | $226 | $5 |
| Furosemide | 41 | $217 | $5 |
| Spironolactone | 32 | $191 | $6 |
| Simvastatin | 14 | $147 | $10 |
| Isosorbide Mononitrate Er | 22 | $130 | $6 |
| Hydralazine | 11 | $111 | $10 |
| Hydrochlorothiazide | 14 | $19 | $1 |
Year by year
| 2024 | 1,019 | 145 | 0% (0) | 11% | $131,063 |
| 2023 | 1,226 | 161 | 0% (0) | 11% | $204,048 |
| 2022 | 1,046 | 169 | 0% (0) | None | $128,583 |
| 2021 | 1,007 | 166 | 0% (0) | 14% | $127,480 |
| 2020 | 1,392 | 321 | 0% (0) | 17% | $203,085 |
| 2019 | 2,246 | 474 | 0% (0) | 16% | $300,016 |
| 2018 | 1,773 | 412 | None | 21% | $254,105 |
| 2017 | 1,633 | 360 | 0% (0) | 24% | $211,413 |
| 2016 | 2,017 | 360 | 0% (0) | 27% | $208,872 |
| 2015 | 2,623 | 398 | None | 29% | $273,492 |
| 2014 | 2,427 | 406 | 0% (0) | 28% | $215,622 |
| 2013 | 2,008 | 307 | None | 23% | $135,619 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Eliquis | 36 | $50,650 | $1,407 |
| Xarelto | 28 | $49,855 | $1,781 |
| Jardiance | 25 | $25,258 | $1,010 |
| Entresto | 17 | $19,385 | $1,140 |
| Atorvastatin | 189 | $6,217 | $33 |
| Metoprolol | 142 | $5,063 | $36 |
| Ezetimibe | 23 | $2,372 | $103 |
| Rosuvastatin | 24 | $2,120 | $88 |
| Losartan | 79 | $1,947 | $25 |
| Clopidogrel | 80 | $1,758 | $22 |
| Lisinopril | 85 | $1,726 | $20 |
| Nitroglycerin | 34 | $1,651 | $49 |
| Amlodipine Besylate | 50 | $952 | $19 |
| Carvedilol | 44 | $723 | $16 |
| Furosemide | 62 | $692 | $11 |
| Spironolactone | 40 | $658 | $16 |
| Potassium Chloride | 12 | $636 | $53 |
| Metoprolol | 38 | $601 | $16 |
| Enalapril Maleate | 17 | $576 | $34 |
| Metformin | 11 | $464 | $42 |
| Isosorbide Mononitrate Er | 19 | $352 | $19 |
| Digoxin | 13 | $285 | $22 |
| Hydrochlorothiazide | 15 | $189 | $13 |
| Simvastatin | 12 | $144 | $12 |
2022: 20 drugs
| Eliquis | 33 | $43,377 | $1,314 |
| Xarelto | 26 | $43,048 | $1,656 |
| Metoprolol | 111 | $3,065 | $28 |
| Atorvastatin | 139 | $2,378 | $17 |
| Ezetimibe | 15 | $1,513 | $101 |
| Nitroglycerin | 49 | $1,489 | $30 |
| Losartan | 66 | $1,208 | $18 |
| Rosuvastatin | 15 | $1,130 | $75 |
| Lisinopril | 74 | $939 | $13 |
| Clopidogrel | 72 | $927 | $13 |
| Digoxin | 19 | $911 | $48 |
| Carvedilol | 47 | $900 | $19 |
| Furosemide | 53 | $674 | $13 |
| Amlodipine Besylate | 35 | $550 | $16 |
| Spironolactone | 56 | $398 | $7 |
| Potassium Chloride | 19 | $264 | $14 |
| Enalapril Maleate | 16 | $259 | $16 |
| Metoprolol | 24 | $181 | $8 |
| Isosorbide Mononitrate Er | 14 | $122 | $9 |
| Pantoprazole | 17 | $69 | $4 |
2021: 21 drugs
| Xarelto | 53 | $57,498 | $1,085 |
| Eliquis | 26 | $36,068 | $1,387 |
| Entresto | 13 | $7,475 | $575 |
| Atorvastatin | 145 | $2,371 | $16 |
| Metoprolol | 99 | $2,037 | $21 |
| Losartan | 59 | $1,194 | $20 |
| Nitroglycerin | 20 | $848 | $42 |
| Rosuvastatin | 20 | $801 | $40 |
| Clopidogrel | 85 | $763 | $9 |
| Carvedilol | 52 | $741 | $14 |
| Ezetimibe | 11 | $731 | $66 |
| Digoxin | 11 | $581 | $53 |
| Furosemide | 72 | $488 | $7 |
| Pantoprazole | 16 | $486 | $30 |
| Lisinopril | 59 | $450 | $8 |
| Isosorbide Mononitrate Er | 35 | $372 | $11 |
| Enalapril Maleate | 12 | $360 | $30 |
| Amlodipine Besylate | 29 | $262 | $9 |
| Spironolactone | 22 | $190 | $9 |
| Metoprolol | 17 | $107 | $6 |
| Simvastatin | 12 | $84 | $7 |
2020: 27 drugs
| Eliquis | 81 | $93,573 | $1,155 |
| Xarelto | 61 | $57,716 | $946 |
| Entresto | 11 | $7,923 | $720 |
| Atorvastatin | 168 | $3,178 | $19 |
| Metoprolol | 110 | $2,798 | $25 |
| Rosuvastatin | 48 | $2,109 | $44 |
| Losartan | 77 | $1,258 | $16 |
| Carvedilol | 67 | $1,104 | $16 |
| Digoxin | 16 | $1,009 | $63 |
| Ezetimibe | 16 | $954 | $60 |
| Clopidogrel | 84 | $875 | $10 |
| Verapamil Er | 11 | $746 | $68 |
| Potassium Chloride | 15 | $629 | $42 |
| Pantoprazole | 14 | $612 | $44 |
| Nitroglycerin | 22 | $571 | $26 |
| Diltiazem 24hr Er (Cd) | 17 | $525 | $31 |
| Lisinopril | 73 | $503 | $7 |
| Isosorbide Mononitrate Er | 32 | $498 | $16 |
| Amiodarone | 19 | $479 | $25 |
| Amlodipine Besylate | 54 | $437 | $8 |
| Furosemide | 69 | $417 | $6 |
| Hydralazine | 19 | $389 | $20 |
| Enalapril Maleate | 11 | $303 | $28 |
| Simvastatin | 28 | $296 | $11 |
| Metoprolol | 45 | $267 | $6 |
| Hydrochlorothiazide | 22 | $252 | $11 |
| Spironolactone | 22 | $172 | $8 |
2019: 37 drugs
| Eliquis | 126 | $104,390 | $828 |
| Xarelto | 76 | $85,939 | $1,131 |
| Pradaxa | 13 | $15,275 | $1,175 |
| Praluent | 15 | $13,481 | $899 |
| Atorvastatin | 295 | $7,672 | $26 |
| Metoprolol | 166 | $6,895 | $42 |
| Bystolic | 15 | $5,450 | $363 |
| Rosuvastatin | 45 | $3,346 | $74 |
| Ezetimibe | 30 | $3,054 | $102 |
| Prasugrel | 17 | $3,053 | $180 |
| Losartan | 154 | $2,642 | $17 |
| Clopidogrel | 129 | $2,313 | $18 |
| Flecainide Acetate | 22 | $2,052 | $93 |
| Carvedilol | 103 | $1,746 | $17 |
| Diltiazem 24hr Er (Cd) | 16 | $1,519 | $95 |
| Digoxin | 26 | $1,483 | $57 |
| Isosorbide Mononitrate Er | 52 | $1,358 | $26 |
| Nitroglycerin | 39 | $1,058 | $27 |
| Lisinopril | 106 | $969 | $9 |
| Furosemide | 107 | $905 | $8 |
| Dilt-Xr | 13 | $835 | $64 |
| Amlodipine Besylate | 115 | $831 | $7 |
| Amiodarone | 19 | $773 | $41 |
| Valsartan | 19 | $760 | $40 |
| Metoprolol | 74 | $638 | $9 |
| Fenofibrate | 12 | $635 | $53 |
| Simvastatin | 52 | $593 | $11 |
| Toprol Xl | 15 | $584 | $39 |
| Pantoprazole | 22 | $535 | $24 |
| Potassium Chloride | 13 | $429 | $33 |
| Chlorthalidone | 11 | $423 | $38 |
| Hydrochlorothiazide | 48 | $387 | $8 |
| Hydralazine | 17 | $355 | $21 |
| Warfarin | 13 | $351 | $27 |
| Atenolol | 21 | $275 | $13 |
| Pravastatin | 12 | $274 | $23 |
| Spironolactone | 23 | $195 | $8 |
2018: 25 drugs
| Eliquis | 117 | $96,974 | $829 |
| Xarelto | 73 | $65,056 | $891 |
| Bystolic | 21 | $6,902 | $329 |
| Metoprolol | 148 | $6,360 | $43 |
| Atorvastatin | 253 | $6,199 | $25 |
| Prasugrel | 12 | $5,869 | $489 |
| Ezetimibe | 18 | $2,214 | $123 |
| Nitroglycerin | 42 | $1,736 | $41 |
| Rosuvastatin | 40 | $1,471 | $37 |
| Flecainide Acetate | 11 | $1,465 | $133 |
| Clopidogrel | 89 | $1,377 | $15 |
| Losartan | 93 | $1,189 | $13 |
| Digoxin | 16 | $1,167 | $73 |
| Isosorbide Mononitrate Er | 35 | $1,050 | $30 |
| Lisinopril | 105 | $952 | $9 |
| Carvedilol | 78 | $812 | $10 |
| Amiodarone | 15 | $688 | $46 |
| Amlodipine Besylate | 74 | $620 | $8 |
| Simvastatin | 50 | $540 | $11 |
| Furosemide | 81 | $537 | $7 |
| Metoprolol | 56 | $446 | $8 |
| Valsartan | 15 | $440 | $29 |
| Pantoprazole | 14 | $296 | $21 |
| Hydrochlorothiazide | 36 | $251 | $7 |
| Spironolactone | 12 | $133 | $11 |
2017: 28 drugs
| Eliquis | 125 | $68,880 | $551 |
| Xarelto | 55 | $40,510 | $737 |
| Pradaxa | 21 | $15,350 | $731 |
| Effient | 12 | $11,786 | $982 |
| Metoprolol | 170 | $8,205 | $48 |
| Bystolic | 18 | $5,528 | $307 |
| Ezetimibe | 19 | $5,172 | $272 |
| Atorvastatin | 213 | $4,931 | $23 |
| Rosuvastatin | 30 | $2,359 | $79 |
| Digoxin | 24 | $1,556 | $65 |
| Nitroglycerin | 29 | $1,525 | $53 |
| Clopidogrel | 82 | $1,205 | $15 |
| Metolazone | 20 | $1,186 | $59 |
| Carvedilol | 83 | $874 | $11 |
| Lisinopril | 107 | $786 | $7 |
| Isosorbide Mononitrate Er | 24 | $755 | $31 |
| Amiodarone | 19 | $749 | $39 |
| Diltiazem 24hr Er | 14 | $686 | $49 |
| Fenofibrate | 15 | $655 | $44 |
| Losartan | 66 | $555 | $8 |
| Amlodipine Besylate | 69 | $545 | $8 |
| Pantoprazole | 20 | $286 | $14 |
| Warfarin | 16 | $283 | $18 |
| Simvastatin | 36 | $275 | $8 |
| Furosemide | 56 | $263 | $5 |
| Metoprolol | 42 | $247 | $6 |
| Hydrochlorothiazide | 26 | $171 | $7 |
| Spironolactone | 11 | $104 | $9 |
2016: 38 drugs
| Eliquis | 104 | $49,248 | $474 |
| Xarelto | 65 | $35,863 | $552 |
| Effient | 40 | $17,869 | $447 |
| Ranexa | 14 | $11,570 | $826 |
| Crestor | 19 | $9,018 | $475 |
| Zetia | 22 | $8,305 | $377 |
| Brilinta | 16 | $7,154 | $447 |
| Pradaxa | 16 | $6,797 | $425 |
| Atorvastatin | 260 | $6,691 | $26 |
| Metoprolol | 139 | $5,717 | $41 |
| Bystolic | 14 | $4,287 | $306 |
| Clopidogrel | 110 | $2,358 | $21 |
| Niacin Er | 11 | $2,332 | $212 |
| Fenofibrate | 17 | $2,057 | $121 |
| Carvedilol | 106 | $1,461 | $14 |
| Coreg | 13 | $1,268 | $98 |
| Nitroglycerin | 18 | $1,257 | $70 |
| Digoxin | 23 | $1,039 | $45 |
| Diltiazem 24hr Er | 15 | $1,023 | $68 |
| Lisinopril | 123 | $993 | $8 |
| Flecainide Acetate | 13 | $918 | $71 |
| Nitrostat | 31 | $864 | $28 |
| Isosorbide Mononitrate Er | 38 | $827 | $22 |
| Amiodarone | 23 | $720 | $31 |
| Propafenone | 13 | $689 | $53 |
| Valsartan | 22 | $655 | $30 |
| Potassium Chloride | 20 | $654 | $33 |
| Amlodipine Besylate | 75 | $640 | $9 |
| Losartan | 60 | $594 | $10 |
| Furosemide | 108 | $530 | $5 |
| Warfarin | 40 | $471 | $12 |
| Metoprolol | 76 | $393 | $5 |
| Verapamil Er | 11 | $378 | $34 |
| Pantoprazole | 23 | $349 | $15 |
| Pravastatin | 19 | $323 | $17 |
| Simvastatin | 38 | $322 | $8 |
| Hydrochlorothiazide | 40 | $289 | $7 |
| Atenolol | 20 | $107 | $5 |
2015: 43 drugs
| Xarelto | 134 | $66,065 | $493 |
| Effient | 76 | $36,093 | $475 |
| Eliquis | 96 | $34,123 | $355 |
| Zetia | 48 | $15,996 | $333 |
| Pradaxa | 17 | $9,862 | $580 |
| Ranexa | 16 | $9,819 | $614 |
| Crestor | 18 | $8,245 | $458 |
| Brilinta | 20 | $8,239 | $412 |
| Metoprolol | 201 | $8,074 | $40 |
| Atorvastatin | 324 | $7,954 | $25 |
| Niacin Er | 17 | $5,539 | $326 |
| Bystolic | 17 | $3,438 | $202 |
| Omega-3 Acid Ethyl Esters | 16 | $3,119 | $195 |
| Fenofibrate | 11 | $2,950 | $268 |
| Clopidogrel | 154 | $2,876 | $19 |
| Digoxin | 44 | $2,235 | $51 |
| Valsartan | 18 | $2,231 | $124 |
| Flecainide Acetate | 32 | $2,019 | $63 |
| Carvedilol | 128 | $1,646 | $13 |
| Amiodarone | 20 | $1,513 | $76 |
| Potassium Chloride | 36 | $1,190 | $33 |
| Pravastatin | 28 | $1,045 | $37 |
| Lisinopril | 142 | $972 | $7 |
| Losartan | 94 | $852 | $9 |
| Amlodipine Besylate | 114 | $732 | $6 |
| Metoprolol | 103 | $696 | $7 |
| Propafenone | 17 | $666 | $39 |
| Warfarin | 30 | $647 | $22 |
| Diltiazem Er | 12 | $644 | $54 |
| Digox | 11 | $638 | $58 |
| Simvastatin | 83 | $582 | $7 |
| Isosorbide Mononitrate Er | 34 | $544 | $16 |
| Nitrostat | 26 | $509 | $20 |
| Fenofibrate | 11 | $501 | $46 |
| Furosemide | 102 | $427 | $4 |
| Diltiazem 24hr Er | 12 | $402 | $33 |
| Hydrochlorothiazide | 42 | $392 | $9 |
| Pantoprazole | 29 | $365 | $13 |
| Sotalol | 16 | $335 | $21 |
| Spironolactone | 26 | $287 | $11 |
| Hydralazine | 15 | $240 | $16 |
| Famotidine | 13 | $169 | $13 |
| Atenolol | 24 | $126 | $5 |
2014: 40 drugs
| Xarelto | 143 | $71,340 | $499 |
| Effient | 66 | $28,121 | $426 |
| Eliquis | 25 | $10,873 | $435 |
| Metoprolol | 185 | $9,493 | $51 |
| Atorvastatin | 275 | $8,307 | $30 |
| Zetia | 30 | $7,652 | $255 |
| Pradaxa | 19 | $6,264 | $330 |
| Clopidogrel | 199 | $5,154 | $26 |
| Diovan | 23 | $4,439 | $193 |
| Fenofibrate | 12 | $3,698 | $308 |
| Niacin Er | 12 | $3,620 | $302 |
| Lovaza | 12 | $3,045 | $254 |
| Bystolic | 24 | $2,511 | $105 |
| Propafenone | 29 | $2,171 | $75 |
| Potassium Chloride | 65 | $1,933 | $30 |
| Carvedilol | 141 | $1,875 | $13 |
| Flecainide Acetate | 31 | $1,849 | $60 |
| Digox | 29 | $1,697 | $59 |
| Lisinopril | 142 | $1,349 | $9 |
| Diltiazem 24hr Er | 18 | $1,074 | $60 |
| Amlodipine Besylate | 100 | $997 | $10 |
| Losartan | 73 | $997 | $14 |
| Simvastatin | 92 | $857 | $9 |
| Diltiazem Er | 23 | $830 | $36 |
| Hydralazine | 17 | $757 | $45 |
| Digoxin | 14 | $718 | $51 |
| Metoprolol | 95 | $707 | $7 |
| Pravastatin | 28 | $690 | $25 |
| Fenofibrate | 13 | $592 | $46 |
| Isosorbide Mononitrate Er | 29 | $584 | $20 |
| Amiodarone | 16 | $564 | $35 |
| Warfarin | 23 | $508 | $22 |
| Furosemide | 90 | $392 | $4 |
| Nitrostat | 23 | $364 | $16 |
| Hydrochlorothiazide | 33 | $354 | $11 |
| Pantoprazole | 16 | $354 | $22 |
| Verapamil Er | 14 | $342 | $24 |
| Spironolactone | 20 | $211 | $11 |
| Klor-Con 8 | 13 | $203 | $16 |
| Atenolol | 18 | $85 | $5 |
2013: 33 drugs
| Xarelto | 61 | $27,986 | $459 |
| Ranexa | 29 | $13,462 | $464 |
| Clopidogrel | 246 | $11,186 | $45 |
| Atorvastatin | 232 | $9,621 | $41 |
| Metoprolol | 144 | $6,416 | $45 |
| Diovan | 34 | $6,041 | $178 |
| Multaq | 19 | $5,997 | $316 |
| Pradaxa | 19 | $5,137 | $270 |
| Zetia | 18 | $4,561 | $253 |
| Fenofibrate | 16 | $2,761 | $173 |
| Carvedilol | 126 | $1,903 | $15 |
| Losartan | 95 | $1,702 | $18 |
| Diltiazem 24hr Er | 14 | $1,553 | $111 |
| Flecainide Acetate | 23 | $1,390 | $60 |
| Isosorbide Mononitrate Er | 51 | $1,300 | $25 |
| Lisinopril | 116 | $1,161 | $10 |
| Simvastatin | 103 | $1,113 | $11 |
| Amlodipine Besylate | 78 | $907 | $12 |
| Amiodarone | 25 | $848 | $34 |
| Metoprolol | 63 | $776 | $12 |
| Potassium Chloride | 13 | $616 | $47 |
| Warfarin | 18 | $518 | $29 |
| Pantoprazole | 19 | $462 | $24 |
| Pravastatin | 19 | $433 | $23 |
| Furosemide | 72 | $398 | $6 |
| Digox | 25 | $370 | $15 |
| Hydralazine | 22 | $294 | $13 |
| Nitrostat | 19 | $281 | $15 |
| Famotidine | 20 | $232 | $12 |
| Bumetanide | 13 | $188 | $14 |
| Hydrochlorothiazide | 47 | $184 | $4 |
| Spironolactone | 14 | $141 | $10 |
| Atenolol | 11 | $94 | $9 |
Money from drug and device companies
$36 in 2025
| 2025 | 2 | 2 | None | $36 |
| 2024 | 9 | 19 | None | $864 |
| 2023 | 9 | 14 | None | $474 |
| 2022 | 6 | 7 | None | $173 |
| 2021 | 5 | 7 | None | $146 |
| 2020 | 4 | 4 | None | $250 |
| 2019 | 15 | 48 | None | $1,248 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Symplicity G3 | $20 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $17 | 1 payment
|
See all 2 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-10-20 | Lifevest | $17 |
| Medtronic | Meals · 2025-01-13 | Symplicity G3 | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $864
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $206 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $176 | 7 payments
|
| Abiomed | Impella | $173 | 1 payment
|
| Medtronic | Symplicity G3 | $87 | 2 payments
|
| Lantheus Medical Imaging | Definity | $81 | 3 payments
|
| Boston Scientific | Watchman Flx | $64 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $30 | 1 payment
|
| Abbott Laboratories | Assurity | $27 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20 | 1 payment
|
2023: $474
| Novartis Pharmaceuticals | Leqvio | $136 | 4 payments
|
| Inari Medical | Ct Thrombectomy System Kit | $134 | 1 payment
|
| Abbott Laboratories | Assurity | $45 | 2 payments
|
| Lantheus Medical Imaging | Definity | $42 | 2 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $31 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $28 | 1 payment
|
| Terumo Medical | Azur Cx Detachable | $23 | 1 payment
|
| Medtronic | Telescope | $21 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $15 | 1 payment
|
2022: $173
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $51 | 1 payment
|
| Medtronic | Euphora | $46 | 2 payments
|
| AngioDynamics | Angiovac | $22 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $21 | 1 payment
|
| Abbott Laboratories | Merlin@Home | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $12 | 1 payment
|
2021: $146
| Medtronic | Telescope | $49 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $33 | 2 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $27 | 1 payment
|
| Abbott Laboratories | Xience Sierra Coronary Stent | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $12 | 1 payment
|
2020: $250
| Medtronic Vascular | Azure | $113 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $86 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $26 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $24 | 1 payment
|
2019: $1,248
| Medtronic Vascular | Mycarelink Smart | $503 | 9 payments
|
| Pfizer | Vyndaqel | $161 | 9 payments
|
| Amgen | Repatha | $142 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $77 | 5 payments
|
| Actelion Pharmaceuticals US | Uptravi | $70 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $48 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $45 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $43 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 2 payments
|
| Abiomed | Impella | $33 | 2 payments
|
| Astellas Pharma US | Lexiscan | $24 | 1 payment
|
| Medline Industries | None | $22 | 1 payment
|
| Sanofi-Aventis U.S. | Praluent | $17 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $16 | 1 payment
|
| Aegerion Pharmaceuticals | Juxtapid | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1528034154
- Licence
- CA A111777, MA 227615, NC 116778California A111777: Current · expires 2027-12-31
- Group
- Sutter Bay Medical Foundation · Alameda Health System
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A1117770
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2006-02-24
- NPI last updated
- 2025-06-24
- NPI record certified
- 2025-06-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3300 Webster St, Oakland, CA, 94609